Mendes Rogério Rafael DA Silva, Zatz Rafael Ferreira, Modolin Miguel Luiz Antonio, Busnardo Fábio DE Freitas, Gemperli Rolf
Hospital das Clínicas, School of Medicine, University of São Paulo, São Paulo, SP, Brazil.
Rev Col Bras Cir. 2018;45(3):e1719. doi: 10.1590/0100-6991e-20181719. Epub 2018 Jun 18.
to evaluate the primary outcome of local complications and late recurrence in patients with hidradenitis suppurativa undergoing radical resection and specific reconstruction.
we conducted a retrospective analysis of the medical records of patients attended by the Plastic Surgery Service of the Clinics Hospital, Medical School, USP, between 2010 and 2016. We included patients who underwent radical resection of hidradenitis suppurativa in advanced stage and reconstruction through primary closure, grafts or flaps.
we analyzed 34 lesions in 19 patients, of which 64.5% had local complications, though with 73.5% efficient healing after 12 weeks postoperatively. We observed late recurrence in 47%, but in isolation, 22.2% of the reconstructions with locoregional flaps had recurrence after one year.
extensive and radical resection of the disease associated with locoregional flap coverage (pedicled or perforating) has been shown to be the best management in terms of late results.
评估接受根治性切除及特定重建手术的化脓性汗腺炎患者局部并发症和晚期复发的主要结局。
我们对2010年至2016年间在圣保罗大学医学院临床医院整形科就诊的患者病历进行了回顾性分析。我们纳入了晚期化脓性汗腺炎接受根治性切除并通过一期缝合、植皮或皮瓣进行重建的患者。
我们分析了19例患者的34处病变,其中64.5%出现局部并发症,不过术后12周时愈合有效率为73.5%。我们观察到47%有晚期复发,但单独来看,22.2%的局部皮瓣重建在一年后出现复发。
就远期效果而言,广泛根治性切除该疾病并采用局部皮瓣覆盖(带蒂或穿支)已被证明是最佳治疗方法。